Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Pipeline
Cancer Program
Fibrosis Program
Clinical Trial
Investor Information
Welcome
Investor Fact Sheet
Investor Presentations
Media
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Publications
Annual Reports
Half Yearly Reports
Quarterly Reports
Research Reports
ASX Announcements
Filter by Year:
2023
2022
2021
2020
2019
2018
8-Nov-2021
Placement and Underwritten Entitlement Offer to Raise $12.4m
4-Nov-2021
Amplia and CRUK agree to Amend Licence Terms - AMP886
4-Nov-2021
Trading Halt
27-Oct-2021
Quarterly Activities and Cashflow Reports - Sep 2021 Qtr
26-Oct-2021
Amplia Appoints New Oncology Clinical Advisor
19-Oct-2021
Amplia Provides Updated Investor Presentation
14-Oct-2021
Amplia Receives $1.1m R&D Tax Incentive
1-Oct-2021
Amplia Appoints New Chief Financial Officer
30-Sep-2021
New Garvan Publication Supports Amplia Phase 2 Design
28-Sep-2021
Proactive Investors Lifesciences Webinar Presentation
Previous
1
2
3
4
5
6
7
8
9
Next
